Today

Agents

Chat

Arena

Discover

More

App

Amneal Pharmaceuticals Q2 Revenue USD 796 Million - AMRX News | Rallies

Amneal Pharmaceuticals Q2 Revenue USD 796 Million

AMRX•2026-07-30

Amneal Pharmaceuticals reports second-quarter results

Jul 30 (Reuters) - Amneal Pharmaceuticals Q2 net income USD 58 million.

Q2 adjusted EPS USD 0.3 vs. IBES estimate USD 0.22
Q2 adjusted EBITDA USD 206 million

Related News

Bloom Energy Corporation <BE.N>: Wells Fargo cuts target price to $176 from $217

BE•2026-07-30

Boston Scientific Corp <BSX.N>: Leerink Partners cuts target price to $60 from $74

BSX•2026-07-30

Valero Energy beats quarterly profit estimates on higher refining margins

•

2026-07-30

Norwegian Cruise Q2 revenue meets estimates

NCLH•2026-07-30

Conmed Corporation <CNMD.N>: Wells Fargo raises target price to $46 from $39

CNMD•2026-07-30